1. Home
  2. WTO vs EVAX Comparison

WTO vs EVAX Comparison

Compare WTO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$2.54

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

EVAX

Evaxion Biotech

HOLD

Current Price

$3.49

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTO
EVAX
Founded
2008
2008
Country
China
Denmark
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
31.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
WTO
EVAX
Price
$2.54
$3.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
25.9K
29.9K
Earning Date
08-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$1.20
52 Week High
$4.50
$12.15

Technical Indicators

Market Signals
Indicator
WTO
EVAX
Relative Strength Index (RSI) 48.07 49.43
Support Level $0.79 $2.70
Resistance Level $3.41 $4.64
Average True Range (ATR) 0.29 0.33
MACD -0.08 -0.01
Stochastic Oscillator 16.83 47.38

Price Performance

Historical Comparison
WTO
EVAX

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: